<DOC>
	<DOCNO>NCT00067431</DOCNO>
	<brief_summary>The purpose study compare safety efficacy two concentration range valproate use Depakote Sprinkle Capsules adjunctive therapy treatment partial seizure , without secondary generalization , child 3-10 year .</brief_summary>
	<brief_title>A Study Safety Efficacy Depakote Sprinkle Capsules Treatment Partial Seizures Children</brief_title>
	<detailed_description />
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Epilepsies , Partial</mesh_term>
	<mesh_term>Valproic Acid</mesh_term>
	<criteria>INCLUSION CRITERIA : Subject diagnosis partial seizure with/without secondary generalization , support : Observed ictal event consistent partial seizure : With/ without secondary generalization ; Documented reliable observer 1 follow 2 : EEG time past demonstrate focal abnormality consistent partial seizure ; OR , absence demonstrable EEG abnormality : MRI/CT scan evidence focal CNS lesion consistent partial seizure On stable dose 1 2 antiepileptic drug ( ) ( AED ) valproate , least 1 month Not take valproate currently receive valproate result trough concentration le 40 mcg/mL History least 4 partial seizures/month 2 month prior screen Parent/caregiver able keep accurate seizure diary EXCLUSION CRITERIA : History follow : LennoxGastaut syndrome ; Primary generalize seizure ; Infantile spasms ; Mixed seizure disorder include atypical absence ; Myoclonic atonic seizure ; Pseudoseizures Epilepsia Partialis Continuans ( EPC ) Has status epilepticus past 6 month Has significant history follow would confound study result : Cardiac ( include clinically important abnormality ECG ) ; Renal ; Psychiatric ( include psychosurgery ) ; Oncologic ; Endocrine ; Metabolic ; Pancreatic ; Hepatic disease ( include clinical/serological history hepatitis ) ; Urea cycle disorder Has : Expanding CNS neoplasm ; Active CNS infection ; Demyelinating disease ; Degenerative neurological disease ; Progressive encephalopathy ; Progressive CNS disease Has platelet count less equal 100,000/mcL Has blood chemistry ALT/AST value ( ) great equal 2 time upper limit normal screening Requires anticoagulant drug therapy Not expect able maintain dose prestudy AEDs , exclude valproate , throughout study Receiving systemic chemotherapy Has take lamotrigine , felbamate , pemoline , within past 3 month prior screen Has ketogenic diet within 30 day prior screen Considered investigator nonresponder valproate treatment epilepsy ( e.g. , Despite adequate trial serum concentration 60 mcg/mL great , subject continue inadequate seizure control )</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>10 Years</maximum_age>
	<verification_date>August 2006</verification_date>
	<keyword>Partial Seizures</keyword>
</DOC>